NCT06025292

Brief Summary

We will be directly comparing a high-quality protein diet composed primarily of lean pork loin (PORK) to a lower-quality plant-based protein diet (PLANT) in individuals with prediabetes on muscle and whole-body protein turnover and glucose regulation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Sep 2024Nov 2026

First Submitted

Initial submission to the registry

August 29, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

September 11, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

July 18, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

August 29, 2023

Last Update Submit

July 17, 2025

Conditions

Keywords

Lean porkMuscle Protein SynthesisProteinPlant-Based

Outcome Measures

Primary Outcomes (2)

  • Muscle Protein Synthesis

    Mixed muscle protein synthesis expressed as the fractional synthetic rate.

    24 hours

  • Whole Body Protein Balance

    Amount of net protein gained per unit of time.

    24 hours

Secondary Outcomes (2)

  • Whole Body Protein Synthesis

    24 hours

  • 24-hour Mean Glucose

    24 hours

Other Outcomes (3)

  • Whole Body Protein Breakdown

    24 hours

  • Whole Body Protein Flux

    24 hours

  • Glucose Regulation and Homeostasis

    24 hours

Study Arms (2)

High Quality Protein Intake - Lean Pork

ACTIVE COMPARATOR

Meal patterns will mimic a standard American diet (50% carbohydrate, 15% protein, 35% fat), providing an isonitrogenous 0.8 g/kg/d protein, and meeting individual estimated daily energy requirements. We have chosen 0.8 g/kg/d as it is the recommend dietary allowance for protein in the US. This arm's protein source will be from lean pork.

Other: Lean Pork vs Plant-Based Protein

Low Quality Protein Intake - Plant-Based

ACTIVE COMPARATOR

Meal patterns will mimic a standard American diet (50% carbohydrate, 15% protein, 35% fat), providing an isonitrogenous 0.8 g/kg/d protein, and meeting individual estimated daily energy requirements. We have chosen 0.8 g/kg/d as it is the recommend dietary allowance for protein in the US. This arm's protein source will be from plant-based protein (ie impossible burger, black bean burger, soy, etc).

Other: Lean Pork vs Plant-Based Protein

Interventions

Participants will eat prepared study meals for three days that have either protein sourced from lean pork or plant-based sources.

High Quality Protein Intake - Lean PorkLow Quality Protein Intake - Plant-Based

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Males and females ages 40-65 years.
  • \. BMI 25 to ≤40 kg/m2 (or body fat % ≥25% in males or ≥36% in females)
  • \. Capable of providing informed consent.
  • \. COVID-19 negative and/or asymptomatic.
  • \. Willing to abstain from drinking alcohol or consuming marijuana and CBD products during the 4-day study meal period
  • \. HbA1c: 5.7-6.4% or fasting glucose 100-125 mg/dL

You may not qualify if:

  • \. Participant who does not/will not eat animal protein sources.
  • \. Allergy to wheat, soy, or common ingredients in plant-based protein products.
  • \. Body mass index \<25 kg/m2 or \>40 kg/m2.
  • \. Hemoglobin \<10g/dL at screening.
  • \. Platelets \<150,000/uL at screening.
  • \. History of chemotherapy or radiation therapy for cancer in the 6 months prior to enrollment.
  • \. History of gastrointestinal bypass/reduction surgery.
  • \. Pregnant or lactating individuals.
  • \. History of a chronic inflammatory disease (e.g. Lupus, Crohn's disease)
  • \. Currently receiving androgen (e.g., testosterone) or anabolic (e.g., GH, IGF-I) therapy.
  • \. Currently using prescription blood thinning medications.
  • \. Currently using corticosteroid medications (cortisone, hydrocortisone, prednisone, etc.).
  • \. Unable or unwilling to suspend aspirin use for 7 days prior to Visit 3 and Visit 7.
  • \. Unwilling to avoid using protein or amino-acid supplements during participation.
  • \. Unwilling to fast overnight.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

RECRUITING

MeSH Terms

Conditions

HyperglycemiaPrediabetic State

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesDiabetes MellitusEndocrine System Diseases

Study Officials

  • David Church, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Church, PhD

CONTACT

Amanda Gwin, PA-C

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 6, 2023

Study Start

September 11, 2024

Primary Completion (Estimated)

May 31, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

July 18, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations